Ginkgo Biloba Does Not Improve Cognitive Function In MS: A Randomized Placebo-controlled Trial
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 116 |
| Sex | Both Genders |
| Age Range | 45-64 |
Supplementation of 240mg EGb-791 daily failed to improve cognitive symptoms in multiple sclerosis patients as assessed by PASAT, Stroop tests, COWAT, and CVLT-II delayed free recall.
